Pay in 4 interest-free payments of $6.24 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Glucagon-like peptide-1 receptor agonists in neurodegenerative diseases: promises and challenges
Data from ESC Congress 2024 offered further insight into the trial, with analysis of individual components of the primary endpoint revealing use of finerenone was associated with an 18% relative reduction in incidence of heart failure hospitalization (RR, 0.82
Studies show that patients who discontinue semaglutide regain about two-thirds of their lost weight within one year
The proportion of incident users being diagnosed with obesity increased substantially between 2019 and 2023
US$ 26.12
US$ 26.42
US$ 20.05
US$ 22.92
US$ 25.38
US$ 21.79
